WO/2016/130080 FEED SYSTEM FOR CRYSTAL GROWING SYSTEMS||WO||18.08.2016|
||PCT/SG2015/000044||SUNEDISON SEMICONDUCTOR LIMITED||HARINGER, Stephan|
A system for growing a crystal ingot from a melt includes a housing and a feed system. The housing defines a growth chamber and an ingot removal chamber positioned above the growth chamber. The feed system includes an enclosure, a feed material reservoir positioned within the enclosure, and a feed channel including an intake end and an outlet end. The intake end is configured to receive feed material from the feed material reservoir. The housing has an opening in communication with the removal chamber and a connector proximate the opening, and the enclosure has an opening and a connector configured to mate with the housing connector. The feed channel is moveable between a retracted position and an extended position in which the feed channel extends through the opening in the housing and the outlet end is positioned within the removal chamber.
WO/2016/130082 PAINLESS DRUG IMPLANTER||WO||18.08.2016|
||PCT/SG2015/050022||LIM, Chee Yen||LIM, Chee Yen|
The present invention relates to a drug implant device which delivers a drug load to the body painlessly. The present invention achieves the painless drug implantation by adopting two principles: (1) rapid perpendicular insertion of fine cannula is painless and that (2) pain is incurred only when the occupied volume caused by the implant process is increased. Therefore, instead of inserting a cannula and injection a volume of drug, which increases the occupied volume of the injection process due to additional volume of the drug, the present invention retracts the cannula in order to dispose the drug into the body. The retraction of cannula does not increase the occupied volume therefore incurs no pain. In the preferred embodiment, the drug implant device (100) comprises a cannula (300) with a bevelled tip, a drug load (320) and an inner rod (340), wherein the drug load (320) and the inner rod (340) are slidably disposed within the cannula (300), and that the drug load (320) is disposed at the bevelled end of the cannula (300) and that the inner rod (340) is disposed adjacent to the drug load (320).
WO/2016/130079 VEHICLE BOOKING SYSTEM AND METHOD THEREOF||WO||18.08.2016|
||PCT/SG2015/000037||GRABTAXI HOLDINGS PTE LTD||LAW HUI HORNG, Ryan|
The present invention relates to a vehicle booking system having a server configured to communicate with a plurality of vehicles, such that the server is configured to receive and store a plurality of vehicle booking requests in a vehicle booking requests database and the server is configured to identify and filter a plurality of undesirable vehicle booking requests from the plurality of vehicle booking requests to obtain a plurality of desirable vehicle booking requests and transmit the plurality of desirable vehicle booking requests to the plurality of vehicles. Further, the present invention provides a method of booking a vehicle.
WO/2016/130078 APPLICATION RECOMMENDATION DEVICES AND APPLICATION RECOMMENDATION METHOD||WO||18.08.2016|
||PCT/SG2015/000036||RAZER (ASIA-PACIFIC) PTE. LTD.||GIANNUZZI, Joseph Mario|
According to various embodiments, an application recommendation device may be provided. The application recommendation device may include: a metrics determination circuit configured to determine a plurality of metrics; and a user input circuit configured to receive user input; a weight determination circuit configured to determine a plurality of weights based on the user input; a weighting circuit configured to determine a weighted metric based on weighting the plurality of metrics based on the plurality of weights; and a recommendation determination circuit configured to determine a recommended application based on the weighted metric.
WO/2016/130086 DEVELOPMENT OF ABCG2-SENSITIVE FLUORESCENT PROBE FOR ISOLATION OF ABCG2 LOW NEURAL STEM/PROGENITOR CELLS||WO||18.08.2016|
||PCT/SG2016/050067||NATIONAL UNIVERSITY OF SINGAPORE||CHANG, Young-Tae|
The present invention relates to the synthesis and characterization of an Abcg2 targeted fluorescence probe (compound of formula I), as well as live imaging of neural stem/progenitor cells (NSPCs) and isolation of live NSPCs using said probe.
WO/2016/130083 METHOD AND APPARATUS FOR DERIVING MEAN ARTERIAL PRESSURE OF A SUBJECT||WO||18.08.2016|
||PCT/SG2015/050502||NITTO DENKO CORPORATION||AUNG, Aye|
A method of deriving mean arterial pressure of a subject is disclosed. The method comprises (i) receiving (202) data relating to at least one cardiac cycle of a bio-signal from the subject; (ii) normalizing the received data relating to the at least one cardiac cycle; (iii) calculating (206) an area enclosed by the normalized received data to obtain a normalized area; (iv) calculating (208) a heart rate of the subject from the at least one cardiac cycle; and (v) deriving (210) the mean arterial pressure from the normalized area and heart rate. A related apparatus is also disclosed.
WO/2016/130087 CONTROLLING TIMING OF PLANT FLOWERING||WO||18.08.2016|
||PCT/SG2016/050068||TEMASEK LIFE SCIENCES LABORATORY LIMITED||ITO, Toshiro|
The present invention relates to the field of plant flowering and more particularly to controlling the timing of plant flowering. More specifically, the present invention relates to devernalization of plants for controlling the timing of plant flowering.
WO/2016/130088 IDENTIFICATION OF NOVEL SINGLE POLYMORPHISMS IN KCNH2 GENE AND USES THEREOF||WO||18.08.2016|
||PCT/SG2016/050069||SINGAPORE HEALTH SERVICES PTE LTD||MEHTA, Ashish|
The present invention relates to novel single polymorphisms in the KCNH2 and their applications in molecular profiling of long QT syndrome 2.
WO/2016/130092 NON-MEMBRANE DISRUPTIVE P53 ACTIVATING STAPLED PEPTIDES||WO||18.08.2016|
||PCT/SG2016/050079||AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH||TAN, Yaw Sing|
The present invention relates to non-membrane disruptive and p53 activating stapled peptides, as well as methods of treatment of cancer involving the use of these peptides. In one embodiment, the peptide comprises or consist of the amino acid sequence of TSFXaa1EYWXaa3LLXaa2, where Xaa1 is (R)-2-(7'-octenyl)alanine or derivative thereof, or is (R)-2-(4'-pentenyl)alanine or derivative thereof; and Xaa2 and Xaa3 are independently any type of amino acid or modified amino acid. In another embodiment, the peptide comprising or consisting of the amino acid sequence of TSFXaa1EYW Xaa3LLXaa2ENXaa5, wherein Xaa1 and Xaa3 are any type of amino acid or modified amino acid; Xaa2 is S, or P, or (S)-2-(4'-pentenyl)alanine or a derivative of (S)-2-(4'-pentenyl)alanine; and wherein Xaa5 is F or Y.
WO/2016/130091 METHODS OF ENCODING AND STORING MULTIPLE VERSIONS OF DATA, METHOD OF DECODING ENCODED MULTIPLE VERSIONS OF DATA AND DISTRIBUTED STORAGE SYSTEM||WO||18.08.2016|
||PCT/SG2016/050074||NANYANG TECHNOLOGICAL UNIVERSITY||JAGADEESH, Harshan|
There is provided a method of encoding multiple versions of data. The method includes computing a difference between a version of a data object and a subsequent version of the data object to produce a difference object, determining a sparsity level of the difference 10 object; determining whether the sparsity level satisfies a predetermined condition; and compressing the difference object to produce a compressed difference object and erasure encoding the compressed difference object to produce a codeword if the sparsity level is determined to satisfy the predetermined condition. There is also provided a corresponding method of decoding encoded multiple versions of data, a method of storing multiple 15 versions of data in a distributed storage system, and a distributed storage system.